Supplement Makers Push FDA to Widen Ingredient Rules
At a public meeting sought by the Natural Products Association, the industry asked the FDA to let peptides and novel probiotics into dietary supplements.
Health News
Business News coverage from Health and Beauty Top.
FDA Sends 30 Warning Letters to Telehealth GLP-1 Sellers
The agency targeted false and misleading claims about compounded GLP-1 products sold on telehealth websites, its second such batch since fall 2025.
Hims & Hers Posts $2.35B Year as GLP-1 Scrutiny Grows
The telehealth company reported 2.5 million subscribers and guided 2026 revenue to $2.7–2.9 billion while defending its weight-loss business.
FDA Moves to Restrict Compounded GLP-1 Copycats
The agency says it will act against non-approved compounded versions of GLP-1 weight-loss drugs mass-marketed by telehealth sellers.
FDA Warning Letter Hits Bee Supplement Maker CC Pollen
The agency says the Arizona company's bee pollen and royal jelly supplements were made under conditions that violate federal quality rules.